Summary
The intrathecal (i.th., T 8–10) administration in conscious rats of the 5-hydroxytryptamine (5-HT)1A agonist 8-OH-DPAT (10 nmol), and to a lesser extent the 5-HT1B agonist CGS 12066B (6 nmol), resulted in a blood pressure reduction and a bradycardia. These responses were prevented by the i.th. pretreatment with substance P (SP) (6.5 nmol) and enhanced following pretreatment with the non-peptide SP antagonist CP-96,345 (10 nmol). The partial 5-HT1A agonist 8-MeO-CLEPAT (10 nmol) had by itself small cardiovascular effects. Following the pretreatment with SP, 8-MeO-CLEPAT caused a pressor response and a tachycardia whereas the opposite effects were observed following pretreatment with the SP antagonist. These results support the notion of a functional interaction between serotonergic and SP mechanisms at the level of the preganglionic sympathetic nerves in the spinal cord.
Similar content being viewed by others
References
Agnati LF, Fuxe K, Benfenati F, Zini I, Hökfelt T (1983) On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of [3H]5-HT binding sites. Acta Physiol Scand 117: 299–301
Appel NM, Wessendorf MW, Elde RP (1986) Coexistence of serotonin- and substance P-like immunoreactivity in nerve fibers apposing identified sympathoadrenal preganglionic neurons in rat intermediolateral cell column. Neurosci Lett 65: 241–246
Backmann SB, Henry JL (1984) Effects of substance P and thyreotropin-releasing hormone on sympathetic preganglionic neurons in upper thoracic intermediolateral nucleus of the cat. Can J Physiol Pharmacol 62: 248–251
Chalmers J, Kapoor V, Mills E, Minson J, Morris M, Pilowsky P, West M (1987) Do pressor neurons in the ventral medullae release amines and neuropeptides? Can J Physiol Pharmacol 65: 1598–1604
Cox BF, Schelper RL, Faraci FM, Brody MJ (1988) Autonomic, sensory, and motor dysfunction following intrathecal administration of three substance P antagonists. Exp Brain Res 70: 61–72
Cridland RA, Yashpal K, Ramitu W, Gauthier S, Henry JL (1987) Distribution of label after intrathecal administration of125I-substance P in the rat. Peptides 8: 213–283
Danzebrink RM, Gebhart GF (1991) Evidence that spinal 5-HT1 5-HT2, and 5-HT3 receptor subtypes moderate responses to noxious colorectal distension in the rat. Brain Res 536: 64–75
Davies JE, Roberts MHT (1981) 5-Hydroxytryptamine reduces substances P responses on dorsal horn interneurons: a possible interaction of neurotransmitters. Brain Res 217: 399–404
Eide PK, Hole K (1988) Intrathecal substance P modulates the depressant effect of 5-methoxy-N-,N-dimethyltryptamine on a reflex response to radiant heat in mice. Neurosci Lett 90: 203–207
Fozard JR, Mir AK, Middlemiss DN (1987) Cardiovascular response to 8-hydroxy-2-(din-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol 9: 328–347
Frank J, Fried G, Brodin E (1989) Substance P enhances the release of endogenous serotonin from rat ventral spinal cord. Eur J Pharmacol 174: 85–90
Gradin K, Persson B (1992) Cardiovascular effects of intrathecal administration of substance P in the rat: interactions with serotonergic mechanisms. J Neural Transm 87: 199–213
Heike CJ, Charlton CG, Wiley RG (1986) Studies on the cellular localization of spinal cord substance P receptors. Neuroscience 2: 523–533
Heike CJ, Phillips ET, O'Neil JT (1987) Intrathecal administration of a substance P antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action. J Pharmacol Exp Ther 242: 131–136
Lundberg JM, Stjärne L (1984) Neuropeptide Y (NPY) depresses the secretion of3H-noradrenaline and the contractile response evoked by field stimulation in rat vas deferens. Acta Physiol Scand 120: 477–479
Mir AK, Fozard R (1989) Hydroxytryptamine in central cardiovascular regulation. In: Saxena PR, Wallis W, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine: prospective therapeutic applications. Kluwer, Dordrecht, pp 247–257
Monroe PJ, Smith DJ (1985) Demonstration of an autoreceptor modulating the release of [3H] 5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation. J Neurochem 45: 1886–1894
Neale RF, Fallon SL, Bogar WC, Wosley JWF, Martin LL, Stanc GA, Glaeser BS, Sinton CM, Williams M (1987) Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1 B agonist. Eur J Pharmacol 136: 1
Schwab EF, Zemlan FP, Murphy RM (1989) Dominant spinal cord 5-HT receptor, the 5-HT-1A: relations to pain. Soc Neurosci Abstr 15: 546
Snider M, Constantine JW, Lowe JA, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess H-J (1991) Potent nonpeptide antagonist of the substance P (NK1 receptor. Science 251: 435–437
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1: 3–9
Tremblay LE, Maheux R, Bédard PJ (1986) Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRH. Neuropharmacology 25: 419–424
Trolin G (1975) Involvement of alpha-adrenergic receptors at different levels of the central nervous system in regulation of blood pressure and heart rate. Acta Physiol Scand [Suppl 430]
Ward RA, Roberts MHT (1984) Physiological interaction of the coexisting neurochemicals 5-hydroxytryptamine and substance P. J Anat 138: 576
Xu X-J, Dalsgaard C-J, Wiesenfeld-Hallin (1992) Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation. Eur J Pharmacol 216: 337–344
Yaksh TL, Rudy TA (1976) Chronic catheterization of the spinal subarachnoidal space. Physiol Behav 17: 1031–1036
Yashpal K, Gauthier SG, Henry JL (1987) Substance P given intrathecally at the spinal T9 level increases arterial pressure and heart rate in the rat. J Auton Nerv Syst 18: 93–103
Yosuf APM, Coote JH (1988) Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat. J Auton Nerv Syst 22: 229–236
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gradin, K., Persson, B. Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist. J. Neural Transmission 93, 225–234 (1993). https://doi.org/10.1007/BF01244999
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244999